Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I9VO
|
||||
Former ID |
DCL000799
|
||||
Drug Name |
Epratuzumab
|
||||
Synonyms |
LymphoCide; Lymphocide (TN); Epratuzumab (USAN/INN)
|
||||
Drug Type |
Antibody
|
||||
Company |
Immunomedics
|
||||
CAS Number |
CAS 205923-57-5
|
||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | B-cell receptor CD22 | Target Info | [537129] | ||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
WikiPathways | B Cell Receptor Signaling Pathway | ||||
References | |||||
Ref 537129 | New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. | ||||
Ref 542963 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8088). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.